





ARQL, ADVS, VITA, PWAV, MHO, ABAX Expected to Trade Up After Bullish Patterns Develop
Published in Stocks and Investing on Tuesday, June 14th 2011 at 6:10 GMT by WOPRAI

June 14, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. ARQULE INC (NASDAQ:ARQL), ADVENT SOFTWARE INC (NASDAQ:ADVS), ORTHOVITA INC (NASDAQ:VITA), POWERWAVE TECHNOLOGIES INC (NASDAQ:PWAV), M/I HOMES INC (NYSE:MHO), ABAXIS, INC. (NASDAQ:ABAX) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.
Symbol Company Strategy Pattern Name Strength ARQL ARQULE INC Reversal (Stocks) DWC Trend Line Reversal(4) 3 ADVS ADVENT SOFTWARE INC Reversal (Stocks) DWC Volume Climax 5 VITA ORTHOVITA INC Reversal (Stocks) DWC Trend Line Break(2) 1 PWAV POWERWAVE TECHNOLOGIES INC Reversal (Stocks) DWC Trend Line Break(3) 2 MHO M/I HOMES INC Reversal (Stocks) DWC Support Break(1) 3 ABAX ABAXIS, INC. Breakout (Stocks) DO Trend Line Break(5+) 3Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php
ARQULE INC (NASDAQ:ARQL) - ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. Its lead product ARQ 197 is non-adenosine triphosphate competitive inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in non-small cell lung cancer, c-Met-associated soft tissue sarcomas, pancreatic adenocarcinoma, hepatocellular carcinoma, germ cell tumors, and colorectal cancer. The company is also developing ARQ 621, a Phase I program focused on inhibition of the Eg5 kinesin spindle protein. Its clinical stage products include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. In addition, the company involves in pre-clinical development of B-RAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.
ADVENT SOFTWARE INC (NASDAQ:ADVS) - Advent Software, Inc. provides software and services that automate work flows and data across investment management organizations, as well as the information flows between an investment management organization and external parties. The company develops, markets, and sells stand-alone and client/server software products, hosting services, data and data interfaces, and related maintenance and services that automate, integrate, and support the functions of the front, middle, and back offices of investment management organizations. It also provides professional services, such as consulting, project management, implementation, integration, custom report writing, and training. The companys clients include asset managers, registered investment advisors, prime brokers, fund administrators, hedge funds, family offices, broker dealers, foundations, endowments, fund of funds, and wealth managers. It operates in the United States, Europe, the Middle East, and Africa. Advent Software, Inc. was founded in 1983 and is headquartered in San Francisco, California.
ORTHOVITA INC (NASDAQ:VITA) - Orthovita, Inc., a specialty spine and orthopedic company, develops and markets orthobiologic and biosurgery products. The companys orthobiologics platform offers products for the fusion, regeneration, and fixation of human bone; and the biosurgery platform provides products for controlling intra-operative bleeding/hemostasis. Its orthobiologic product portfolio comprises Vitoss bone graft substitute, a high-porous resorbable beta-tricalcium phosphate bone graft substitute used to help the body guide the three-dimensional regeneration of the patients own bone; Bone Marrow Aspiration System with imbibe needles, syringes, and imbibe disposable delivery instrumentation, which provides spine and orthopedic surgeons with a method for harvesting a patients own bone marrow; Cortoss Bone Augmentation Material, a polymer composite for use in various surgical procedures to provide structural stability and reinforcement of the bones after surgery; and Aliquot Delivery System that facilitates delivery of materials to bony sites, including delivery of Cortoss product directly to the surgical site. The companys biosugery products include Vitagel surgical hemostat, a composite liquid hemostat that combines the biomaterials bovine thrombin and bovine collagen with the patients autologous plasma, and applied in the spine, hip, and knee replacement surgeries; and Vitasure Absorbable Hemostat, a plant-based hemostat product that can be deployed throughout surgery. It sells its products in the United States and internationally through a network of direct sales representatives and independent non-stocking distributors. The company has strategic partnerships with Kensey Nash Corporation; Angiotech Pharmaceuticals (U.S.), Inc.; and Medafor, Inc. Orthovita was founded in 1992 and is headquartered in Malvern, Pennsylvania.
POWERWAVE TECHNOLOGIES INC (NASDAQ:PWAV) - Powerwave Technologies, Inc. engages in the design, manufacture, marketing, and sale of wireless solutions for wireless communications networks worldwide. It offers antennas, boosters, combiners, cabinets, shelters, filters, radio frequency power amplifiers, remote radio head transceivers, repeaters, tower-mounted amplifiers, and advanced coverage solutions for use in frequency bands, including cellular, PCS, 3G, and 4G wireless communications networks. Powerwave Technologies sells its products through its direct sales force, independent sales representatives, and resellers to wireless original equipment manufacturers and individual wireless network operators. It was formerly known as Milcom International, Inc. and changed its name to Powerwave Technologies, Inc. in June 1996. The company was founded in 1985 and is based in Santa Ana, California.
M/I HOMES INC (NYSE:MHO) - M/I Homes, Inc., together with its subsidiaries, engages in the construction and sale of single-family residential properties. The company offers single-family homes, attached townhomes, and condominiums to first-time, move-up, empty-nester, and luxury buyers under the M/I Homes and Showcase Homes trade names. It designs, sells, and builds single-family homes on finished lots, which it develops or purchases ready for home construction. The company also purchases undeveloped land to develop into finished lots for construction of single-family homes and for sale to others. In addition, it provides mortgage financing services, such as originating mortgage loans, as well as offers title services to purchasers of its homes. Further, the company offers insurance services. M/I Homes, Inc. has operations in Columbus and Cincinnati, Ohio; Indianapolis, Indiana; Chicago, Illinois; Tampa and Orlando, Florida; Charlotte and Raleigh, North Carolina; and Virginia and Maryland suburbs of Washington, D.C. As of December 31, 2009, it had 2,410 developed lots and 664 lots under development in inventory, as well as owned raw land expected to be developed into approximately 4,121 lots. The company was founded in 1973 and is based in Columbus, Ohio.
ABAXIS, INC. (NASDAQ:ABAX) - Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements in the medical and veterinarian markets. Its products include point-of-care blood chemistry analyzer, which performs a panel of 14 tests on human patients and 13 tests on veterinary patients marketed under the Piccolo xpress and Piccolo Classic names in the human medical market, and under the VetScan VS2 and VetScan Classic names in the veterinary market. The companys products also include Reagent Discs that handle various technical steps of blood chemistry testing automatically; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, which offer blood count analysis for veterinary applications. In addition, its products comprise VetScan VSpro that assists in the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular disease, hepatic disease, and monitoring therapy, as well as progression of disease states; VetScan canine heartworm rapid test, a test for the detection of dirofilaria immitis in canine whole blood, serum, or plasma; and i-STAT 1 analyzer, a handheld instrument and associated consumables for blood gas, electrolyte, basic blood chemistry, and immunoassay testing for the animal health care market. Further, Abaxiss products consist of Orbos Discrete Lyophilization process, which allows the production of active chemical ingredient in the form of a soluble bead, as well as involves in flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. The company markets and sells its products through a direct sales force and independent distributors world wide. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net